Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3487-3491

  Guo, Chun Yuan ^a   Thomas, William E G ^b   Al Dehaimi, Abdul Wahed ^a   Assiri, Adel M A ^a   Eastell, Richard ^a,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; FEMALE; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE DENSITY; BONE REMODELING; COLLAGEN; COLLAGEN TYPE I; CREATININE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROXYLYSINE; HYPERPARATHYROIDISM; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; POSTMENOPAUSE; PROCOLLAGEN;

EID: 0029798469     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3487     Document Type: Article

References (34)

1. Parfitt AM, Sudhaker RD, Kleerekoper M. 1991 Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res. 6(Suppl 2):s97.
2. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM. 1988 Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab. 67:1294-1298.
3. Warner J, Clifton-Bligh P, Posen S. 1991 Longitudinal changes in forearm bone mineral content in primary hyperparathyroidism. J Bone Miner Res. 6(Suppl 2):s91.
4. Doom L, Lips P, Netelenbos JC, Hackeng WHL. 1993 Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH 1-84) in patients with primary hyperparathyroidism. Bone Miner. 23:233-242.
5. Christiansen P, Steiniche T, Brockstedt H, Mosekilde L, Hessov I, Melsen F. 1993 Primary hyperparathyroidism: iliac crest cortical thickness, structure, and remodelling evaluated by histomorphometric methods. Bone. 14:755-762.
6. Richardson ML, Pozzi-Mucelli RS, Kanter AS, Kolb FO, Ettinger B, Genant HK. 1986 Bone mineral changes in primary hyperparathyroidism. Skelet Radiol. 15:85-95.
7. Silverberg SJ, Shane E, Cruz L, et al. 1989 Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 4:283-291.
8. Eastell R, Kennedy NSJ, Smith MA, Tothill P, Edwards CRW. 1986 Changes in total body calcium following surgery for primary hyperparathyroidism. Bone. 7:269-272.
9. Martin P, Bergmann P, Gillet C, Fuss M, Corvilain J, Geertruyden JV. 1990 Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Arch Intern Med. 150:1495-1497.
10. Mautalen C, Reyes HR, Ghirnghelli G, Fromm G. 1986 Cortical bone mineral content in primary hyperparathyroidism. Changes after parathroidectomy. Acta Endocrinol (Copenh). 111:494-497.
11. Wells SA. 1991 Surgical therapy of patients with primary hyperparathyroidism: long-term benefits. J Bone Miner Res. 6(Suppl 2):s143-s149.
12. Martin P, Bergmann P, Gellet C, et al. 1986 Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med. 146:689-691.
13. Silverberg SJ, Gartenberg F, Jacobs T, et al. 1995 Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab. 811:729-735.
14. Horowitz M, Wishart J, Need AG, Morris H, Philcox J, Nordin BEC. 1987 Treatment of postmenopausal women with hyperparathyroidism. Arch Intern Med. 147:681-685.
15. Marcus R. 1991 Oestrogen and progestins in the management of primary hyperparathyroidism. J Bone Miner Res. 6(Suppl 2):s125-s129.
16. Marcus R, Madvig P, Crim M, Pont A, Kosek J. 1984 Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. Ann Intern Med. 100:633-640.
17. Consensus Development Conference Panel. 1991 Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med. 114:593-597.
18. Rosalki SB, Foo AY. 1984 Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem. 30:1182-1186.
19. Moro L, Gazzarrini C, Modricky C., et al. 1990 High predictivity of galactosylhydroxylysine in urine as an indicator of bone metastases from breast cancer. Clin Chem. 36:772-774.
20. Mole PA, Walkinshaw MH, Gunn A, Paterson CR. 1972 Bone mineral content in patients with primary hyperparathyroidism: a comparison of conservative management with surgical treatment. Br J Surg. 79:263-265.
21. Leppla DC, Snyder W, Pak CYC. 1982 Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism. Invest Radiol. 17:604-606.
22. Diaz-Curiel M, Rapado A, Lopez-Gavilanes E, Peramo B, Diez A. 1990 Type of bone loss involved in the follow-up of surgical or medical treatment of primary hyperparathyroidism. In: Christiansen C, Overgaard K, eds. Osteoporosis. Copenhagan; vol 3:1560-1562.
23. Rao DS, Phillips E, Jacobsen G, Jacobsen G. 1995 Lack of evidence for either continued bone loss, or differences in rated of bone loss between white and black women, in untreated, mild primary hyperparathyroidism [Abstract]. Bone. 16:(Suppl):216s.
24. Silverberg SJ, Gartenberg F, Jacobs TP., et al. 1995 Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab. 80:723-728.
25. Parisien M, Silverberg SJ, Shane E, De La Cruz L, Linday R, Bilezikian JP. 1990 The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab. 70:930-938.
26. Melsen F, Mosekilde L. 1981 The role of bone biopsy in the diagnosis of metabolic bone disease. Orthop Clin North Am. 12:571-602.
27. Eriksen EF, Mosekilde L, Melsen F. 1986 Trabecular bone remodelling and balance in primary hyperparathyroidism. Bone. 7:213-221.
28. Muller H. 1969 Sex, age, and hyperparathyroidism. Lancet. 1:449-450.
29. McGeown MG. 1969 Sex, age, and hyperparathyroidism. Lancet. 1:887-888.
30. Hossain M, Smith DA, Nordin BEC. 1970 Parathyroid activity and postmenopausal osteoporosis. Lancet. 1:809-811.
31. Gallagher JC, Nordin BEC. 1972 Treatment with oestrogens of primary hyperparathyroidism in postmenopausal women. Lancet. 1:503-507.
32. Gallagher JC, Wilkinson R. 1973 The effect of ethiny loestradiol on calcium and phosphorus metabolism of postmenopausal women with primary hyperparathyroidism. Clin Sci Mol Med. 45:785-802.
33. Garton M, Martin J, Stewart A. et al. 1995 Change in bone mass and metabolism after surgery for primary hyperparathyroidism. Clin Endocrinol (Oxf). 42:493-500.
34. Behr W, Barnert J. 1986 Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin Chem. 32:1960-1966.